HbA1c reduction

Biomarker1 paper1 finding

Human trial1

Interventions

1

SMART2D intervention

upin humans1Low certainty

1 study

SMART2D intervention increases HbA1c reduction in humans (adjusted 2.02, 0.20-3.84).
Human trialparticipants at high risk of T2Dn = 84
Proof-of-implementation of the SMART2D intervention: findings from a cluster randomised feasibility trial for prevention and control of type 2 diabetes in socio-economically disadvantaged neighbourhoods in Stockholm, Sweden · medRxiv · 2 Oct 2026 · Preprint

SMART2D intervention →

Latest

4

medRxivHuman trialPreprint3 Oct

Proof-of-implementation of the SMART2D intervention: findings from a cluster randomised feasibility trial for prevention and control of type 2 diabetes in socio-economically disadvantaged neighbourhoods in Stockholm, Sweden

Type 2 diabetes

Endocrine JournalHuman trial1 Oct

Real-world effectiveness and safety of low-dose tirzepatide in Japanese people with type 2 diabetes: a multicenter, retrospective, single-arm, observational study-East Shizuoka Tirzepatide (ESTATE) study

GLP-1 receptor agonists

Journal of the ASEAN Federation of Endocrine SocietiesHumans28 Sep

Dapagliflozin Alone or Combined With Semaglutide: Cardiovascular and Renal Outcomes Among Patients With Type 2 Diabetes Mellitus in a 6-Month Real-World Retrospective Cohort Study in Saudi Arabia

SGLT2 inhibitors

Scandinavian Cardiovascular JournalHuman trial26 Sep

Responder analysis of adaptive postural balance cardiac rehabilitation exercise in patients with coronary artery disease and type 2 diabetes: secondary analysis of a randomized trial

Coronary artery disease